Global Veterinary Medicine Market Infographics Description:
- The Global Veterinary Medicine Market is estimated at US$ 28,806.9 in 2021.
- Global Veterinary Medicine Market is projected to reach US$ 52,636.5 Mn in 2030 at a CAGR of 6.9% from 2021 to 2030.
- Amongst Product Type, the Drugs segment in the global veterinary medicine market is estimated to account for a majority revenue share of 58.2% by 2020 end.
- Among all the animal type segments, the companion animals is expected to register the highest CAGR of over 7.1%, followed by Supermarket/Hypermarket.
- Amongst route of administration, the parenteral route segment in the global Veterinary Medicine market is estimated to account for a majority revenue share of 58.0% by 2020 end.
- Amongst end-use, the veterinary hospitals & clinics segment in the global Veterinary Medicine market is estimated to account for a majority revenue share of 46.8% by 2020 end.
- North America market is expected to dominate the global Veterinary Medicine market. It is expected to account for the largest market revenue share than that of markets in other regions.
- Companies profiled in the report are Novartis AG, Merck Animal Health (Merck & Co., Inc.), Boehringer Ingelheim GmbH, Evonik Industries AG, Zoetis Inc, Elanco Animal Health Incorporated (Bayer Animal Health), Ceva Santé Animale S.A., Virbac SA, Dechra Pharmaceuticals Plc, Vetoquinol SA.
